What amount sold does Tempo Therapeutics, Inc. report in Form D filings?

The latest linked filings report $17.8M sold across 2 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Tempo Therapeutics, Inc.'s most recent SEC filing?

Tempo Therapeutics, Inc.'s most recent Form D filing was on 2026-09-11.

How many investors does Tempo Therapeutics, Inc. have?

The most recent Form D filing lists 43 investor(s).

What type of securities does Tempo Therapeutics, Inc. offer?

Tempo Therapeutics, Inc.'s SEC Form D filings indicate debt offerings.

Tempo Therapeutics, Inc.

CIK: 0001813688·Biotechnology·SAN DIEGO, CA·Corporation

Reported Sold

$17,844,046

Total Filings

Identified Offerings

Last Filed

Sep 11, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Sep 11, 2026Form D — New notice

Reported sold: $14,000,000 · Target: $14,500,000

Rule 506(b)·43 investors

Aug 9, 2021Form D/A — Amendment

Reported sold: $3,844,046 · Target: $3,898,500

Rule 506(b)·39 investors

Jun 2, 2020Form D — New notice

Reported sold: $3,844,046 · Target: $3,898,500

Rule 506(b)·39 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

33%

Latest reported sold across 2 identified offerings

$17,844,046

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Steven Richieri

Related Person

Appears on 2 filings

Westbrook Weaver

Related Person

Appears on 2 filings

Donald Griffin

Related Person

Appears on 2 filings

Richard Hancock

Related Person

Appears on 2 filings

Dino Di Carlo

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Sep 11, 2026	New	$14,500,000	$14,000,000	43
Aug 9, 2021	Amendment	$3,898,500	$3,844,046	39
Jun 2, 2020	New	$3,898,500	$3,844,046	39

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Adela, Inc.

Biotechnology

Offering target: $12,000,000

Filed Oct 19, 2026